Results 111 to 120 of about 4,959 (174)

Elastin as a Novel Extracellular Matrix From Aberrant HDAC4 Expression in PDGF-BB-Induced Orbital Fibroblasts From Graves' Ophthalmopathy Patients. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Chompoowong R   +9 more
europepmc   +1 more source

Ocular surface and meibomian gland evaluation in euthyroid Graves' ophthalmopathy. [PDF]

open access: yesInt Ophthalmol
Lai KKH   +12 more
europepmc   +1 more source

Assessment of Schlemm's canal with swept-source optical coherence tomography in Graves' ophthalmopathy. [PDF]

open access: yesGraefes Arch Clin Exp Ophthalmol
Gün RD   +3 more
europepmc   +1 more source

Treatment of Graves’ ophthalmopathy

Medicina Clínica (English Edition), 2021
Graves' ophthalmopathy is an inflammatory disease with primary involvement of the extraocular muscles and the orbit. It encompasses the most common extra-thyroid manifestation in patients with Graves-Basedow disease. The underlying cause is molecular mimicry with the TSH receptor in ocular fibroblasts, leading to an immuno-mediated pathogenesis ...
Andrés, González-García   +1 more
openaire   +2 more sources

IMMUNOGENETICS OF GRAVES' OPHTHALMOPATHY

Clinical Endocrinology, 1988
SUMMARYWe have performed an immunogenetic analysis of 53 patients with severe Graves' ophthalmopathy, 51 patients with Graves' disease but little or no clinically apparent eye disease, and 90 controls. The distribution of restriction fragment length polymorphisms was analysed in the three groups, using probes for the HLA‐DQα and DRβ regions, the T‐cell
A P, Weetman   +5 more
openaire   +2 more sources

Graves ophthalmopathy

Current Opinion in Ophthalmology, 2001
Graves ophthalmopathy (GO) is an autoimmune disease that typically affects the thyroid gland and the orbit. The roles of the thyroid stimulating hormone receptor and cellular and humoral immunity in the pathogenesis of GO are being investigated. Investigators are gaining insights into the epidemiology of GO as it relates to other ocular and autoimmune ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy